Announcements Trials
Browse Landscape

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 153Observational 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Small Cell Lung Carcinoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma 1

Interventions

atezolizumab 5durvalumab 4Drug Therapy 4Carboplatin 4Psychiatric Rehabilitation 3Immunotherapy 3Topotecan 2Specimen Handling 2Radiotherapy 2Polymerase Chain Reaction 2PM 01183 2Observation 2Mental Status and Dementia Tests 2Magnetic Resonance Spectroscopy 2Immunohistochemistry 2Immune Checkpoint Inhibitors 2Ifosfamide 2Etoposide 2Cisplatin 2Biopsy 2trastuzumab deruxtecan 1nedaplatin 1X-Ray Therapy 1Watchful Waiting 1Vinorelbine 1Tomography, Optical Coherence 1Tissue Banks 1Therapeutics 1Radiation, Ionizing 1Phlebotomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Small Cell Lung Carcinoma × Etoposide × Clear all
NCT06869239 2025-03-11

Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy

Peking University Cancer Hospital & Institute

Recruiting
65 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT06780826 2025-01-17

A Study on the Efficacy of Atezolizumab Combined with Chemotherapy

Shanghai Pulmonary Hospital, Shanghai, China

Recruiting
1,430 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡